Compounds > sb 203580
Page last updated: 2024-09-05

sb 203580 and cgp 74514a

sb 203580 has been researched along with cgp 74514a in 1 studies

Compound Research Comparison

Studies
(sb 203580)		Trials
(sb 203580)		Recent Studies (post-2010)
(sb 203580)		Studies
(cgp 74514a)		Trials
(cgp 74514a)		Recent Studies (post-2010) (cgp 74514a)
3,48941,13714011

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)cgp 74514a (IC50)
Cyclin-T1Homo sapiens (human)1.4
Epidermal growth factor receptorHomo sapiens (human)3.55
Cyclin-dependent kinase 1Homo sapiens (human)0.121
Cyclin-dependent kinase 4Homo sapiens (human)1.7865
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.1867
Interferon-induced, double-stranded RNA-activated protein kinaseHomo sapiens (human)3
Cyclin-A2Homo sapiens (human)0.046
G1/S-specific cyclin-D1Homo sapiens (human)3
G1/S-specific cyclin-E1Homo sapiens (human)0.0215
Cyclin-dependent kinase 2Homo sapiens (human)0.0297
G1/S-specific cyclin-D3Homo sapiens (human)0.573
Dual specificity protein kinase CLK1Homo sapiens (human)0.148
Dual specificity protein kinase CLK2Homo sapiens (human)0.111
Cyclin-dependent kinase 7Homo sapiens (human)0.279
Cyclin-dependent kinase 9Homo sapiens (human)1.4
Cyclin-HHomo sapiens (human)0.279
CDK-activating kinase assembly factor MAT1Homo sapiens (human)0.279
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.026
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.026
Dual specificity protein kinase CLK4Homo sapiens (human)0.104

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A1

Other Studies

1 other study(ies) available for sb 203580 and cgp 74514a

ArticleYear
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

    Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013